» Articles » PMID: 34299909

A Longitudinal Study of the Relationship Between Shift Work and Prostate-Specific Antigen in Healthy Male Workers

Overview
Publisher MDPI
Date 2021 Jul 24
PMID 34299909
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

As shift work has become prevalent globally, it is important to evaluate the health effects of shift work on employees. Several studies have demonstrated a positive association between shift work and prostate cancer. Therefore, we aimed to further examine the relationship between shift work and elevated prostate-specific antigen (PSA). Our study collected data from 66,817 male participants at baseline and followed up for about 6 years. We categorized shift worker status and shift schedule types. To evaluate the risk of elevated PSA on shift workers, we estimated hazard ratios using the Cox proportional hazards regression analyses. During a median follow-up of 4.1 years, 1030 participants developed elevated PSA. The multivariable-adjusted hazard ratio (HR) of elevated PSA for shift workers compared with daytime workers was 1.37 (1.04-1.80). Among shift workers, rotating shift workers (HR = 1.47, 95% CI 1.06-2.03) showed a significantly increased risk of elevated PSA compared with daytime workers. Our longitudinal study provides evidence for an association between shift work, especially rotating shift work, and elevations of PSA.

Citing Articles

Prostate cancer in workers exposed to night-shift work: two cases recognized by the Korean Epidemiologic Investigation Evaluation Committee.

Park S, Ma S, Seo H, Lee S, Lee J, Ye S Ann Occup Environ Med. 2024; 35:e52.

PMID: 38274362 PMC: 10808083. DOI: 10.35371/aoem.2023.35.e52.

References
1.
Alterman T, Luckhaupt S, Dahlhamer J, Ward B, Calvert G . Prevalence rates of work organization characteristics among workers in the U.S.: data from the 2010 National Health Interview Survey. Am J Ind Med. 2012; 56(6):647-59. PMC: 4557703. DOI: 10.1002/ajim.22108. View

2.
Schroder F, Hugosson J, Roobol M, Tammela T, Zappa M, Nelen V . Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet. 2014; 384(9959):2027-35. PMC: 4427906. DOI: 10.1016/S0140-6736(14)60525-0. View

3.
Ganesan S, Magee M, Stone J, Mulhall M, Collins A, Howard M . The Impact of Shift Work on Sleep, Alertness and Performance in Healthcare Workers. Sci Rep. 2019; 9(1):4635. PMC: 6420632. DOI: 10.1038/s41598-019-40914-x. View

4.
Xi S, Tam P, Brown G, Pang S, Shiu S . Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells. J Pineal Res. 2000; 29(3):172-83. DOI: 10.1034/j.1600-079x.2000.d01-64.x. View

5.
Werny D, Thompson T, Saraiya M, Freedman D, Kottiri B, German R . Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev. 2006; 16(1):70-6. DOI: 10.1158/1055-9965.EPI-06-0588. View